Veracyte Inc. (VCYT)
29.33
-0.79 (-2.62%)
At close: Mar 31, 2025, 12:37 PM
Veracyte Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Revenue | 445.76M | 361.05M | 296.54M | 219.51M | 117.48M | 120.37M | 92.01M | 71.95M | 65.08M | 49.5M | 38.19M | 21.88M | 11.63M | 2.65M |
| Cost of Revenue | 147.62M | 112.9M | 101.58M | 74.4M | 41.45M | 36.52M | 33.08M | 28.2M | 25.46M | 21.5M | 16.61M | 12.61M | 7.58M | 2.92M |
| Gross Profit | 298.14M | 248.15M | 194.95M | 145.11M | 76.03M | 83.84M | 58.93M | 43.76M | 39.62M | 28.01M | 21.58M | 9.28M | 4.04M | -280K |
| Operating Income | 16.14M | -85.8M | -41.08M | -81.9M | -35.39M | -15.13M | -22.23M | -26.54M | -28.8M | -33.47M | -29.01M | -23.17M | -18.93M | -15.27M |
| Interest Income | 11.15M | 7.34M | 1.97M | 135K | 594K | 2.35M | n/a | n/a | n/a | n/a | n/a | 5K | 2K | 2K |
| Pretax Income | 25.74M | -76.61M | -36.43M | -81.65M | -34.91M | -12.6M | -23M | -31M | -31.36M | -33.7M | -29.37M | -25.58M | -18.65M | -14.45M |
| Net Income | 24.14M | -74.4M | -36.56M | -75.56M | -35.85M | -16.48M | -23M | -31M | -31.36M | -33.7M | -29.37M | -25.58M | -18.65M | -14.45M |
| Selling & General & Admin | 206.04M | 184.23M | 174.08M | 181.19M | 89.12M | 82.72M | 65.28M | 55.35M | 52.03M | 47.88M | 40.79M | 24.64M | 16.36M | 8.31M |
| Research & Development | 69.29M | 57.3M | 40.6M | 29.84M | 17.2M | 14.85M | 14.82M | 13.88M | 15.32M | 12.8M | 9.8M | 7.81M | 6.61M | 6.68M |
| Other Expenses | 6.67M | 92.41M | 21.35M | 15.98M | 5.09M | 1.4M | 1.2M | 476K | 202K | 140K | 72K | -2.18M | 278K | 819K |
| Operating Expenses | 282M | 333.94M | 236.03M | 227.02M | 111.42M | 98.97M | 81.16M | 70.3M | 68.43M | 61.47M | 50.59M | 32.45M | 22.97M | 14.99M |
| Interest Expense | 2K | 15K | 198K | 241K | 229K | 677K | 1.96M | 4.94M | 2.76M | 378K | 439K | 233K | n/a | n/a |
| Selling & Marketing Expenses | 27.77M | 26.6M | 97.56M | 79.84M | 52.39M | 53.69M | 41.31M | 32.26M | 28.25M | 25.29M | 21.93M | 12.54M | 8.45M | 2.93M |
| Cost & Expenses | 429.62M | 446.85M | 337.62M | 301.42M | 152.87M | 135.5M | 114.24M | 98.49M | 93.89M | 82.97M | 67.2M | 45.06M | 30.56M | 17.91M |
| Income Tax | 1.61M | -2.21M | 133K | -6.09M | 938K | 3.88M | 1.2M | 5.42M | 2.96M | 518K | -664K | -2.94M | -2K | 819K |
| Shares Outstanding (Basic) | 77.61M | 72.64M | 71.55M | 67.89M | 53.24M | 46.14M | 37.02M | 33.93M | 28.83M | 25.94M | 21.64M | 4.16M | 14.2M | 14.2M |
| Shares Outstanding (Diluted) | 79.91M | 72.64M | 71.55M | 67.89M | 53.24M | 46.14M | 37.02M | 33.93M | 28.83M | 25.94M | 21.64M | 4.16M | 14.2M | 14.2M |
| EPS (Basic) | 0.31 | -1.02 | -0.51 | -1.11 | -0.67 | -0.36 | -0.62 | -0.91 | -1.09 | -1.3 | -1.36 | -6.15 | -1.31 | -1.02 |
| EPS (Diluted) | 0.30 | -1.02 | -0.51 | -1.11 | -0.67 | -0.36 | -0.62 | -0.91 | -1.09 | -1.3 | -1.36 | -6.15 | -1.31 | -1.02 |
| EBITDA | 49.2M | -49.41M | -6.98M | -60.18M | -25.77M | -7.81M | -17.12M | -23.76M | -25.09M | -32.53M | -27.76M | -24.35M | -17.94M | -13.83M |
| Depreciation & Amortization | 23.46M | 27.19M | 29.25M | 21.23M | 8.91M | 4.12M | 3.92M | 3.84M | 3.51M | 800K | 1.18M | 999K | 706K | 611K |